Peking University

This study tested a three-drug approach for people with advanced liver cancer that has spread into the main blood vessel of the liver (portal vein). The treatment combines chemotherapy given directly into the liver artery with two oral drugs (lenvatinib and a PD-1 inhibitor). The…

This early-phase study tested a new treatment called C-CAR039 in 3 people with B-cell Non-Hodgkin's lymphoma that had come back or stopped responding to standard therapy. The treatment uses a patient's own immune cells, modified to attack two targets (CD19 and CD20) on cancer cel…

This study tested a mobile health program for overweight or obese pregnant women to help them gain a healthy amount of weight during pregnancy. Two hundred women used a smartphone app with diet and exercise guidance, plus a fitness tracker, for about six months. The goal was to s…

This study tested whether adding chemotherapy directly into the liver's blood supply (HAIC) to standard bile duct drainage could help people with advanced bile duct cancer live longer. 127 adults with inoperable cancer took part. The goal was to see if the combined treatment impr…

This study tested a group writing therapy for Chinese teenagers with PTSD or complex PTSD. 53 teens were split into two groups: one received the writing therapy, the other waited. The therapy involved 5 to 8 group sessions where participants wrote about their trauma. Results show…

This study tested a self-guided online program to help people with high death anxiety feel better. 47 adults completed the 2-hour program or were placed on a waiting list. Researchers measured changes in death anxiety, beliefs, and behaviors at several points over two weeks.

This study tested a group writing therapy for Chinese teenagers with PTSD. 53 teens took part, with half receiving the therapy and half on a waiting list. The therapy involved 5-8 group sessions where they wrote about their trauma. Results showed it helped reduce PTSD and depress…